Keywords: درمان هدفمند; Penile cancer; Squamous cell carcinoma; Systemic therapy; Chemotherapy; Targeted therapy;
مقالات ISI درمان هدفمند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان هدفمند; anticancéreux; antinéoplasique; hygiène bucco-dentaire; mucite; thérapie ciblée; anticancer; antineoplastic; oral hygiene; mucositis; targeted therapy;
Keywords: درمان هدفمند; MET; Adenocarcinoma; Small molecule; Tyrosine kinase inhibitor; Targeted therapy;
Keywords: درمان هدفمند; Cancer; Personalized medicine; Tumour microenvironment; Immunobiology; Targeted therapy; Pharmacogenetics; SmPC (alias SPC); summary of product characteristics; IBD; inflammatory bowel disease; ADCC; antibody-dependent cell-mediated cytotoxicity; CDC; com
Keywords: درمان هدفمند; Urothelial carcinoma; Bladder cancer; Immunotherapy; Checkpoint inhibitors; Chemotherapy; Clinical trials; Targeted therapy; Platinum ineligible;
Keywords: درمان هدفمند; Lung cancer; Adenocarcinoma; Convex endobronchial ultrasound; PD-L1; Targeted therapy;
Keywords: درمان هدفمند; Candida parapsilosis; Drug resistance; Mortality; Targeted therapy;
Keywords: درمان هدفمند; Biguanide; Targeted therapy; Radiotherapy; Irradiation; Thoracic oncology;
Keywords: درمان هدفمند; Lung cancer; Latin America; Immunotherapy; Targeted therapy; Healthcare access;
Keywords: درمان هدفمند; Sarcomatoid renal cell carcinoma; Renal cell carcinoma; Nephrectomy; Chemotherapy; Targeted therapy; Immunotherapy;
Keywords: درمان هدفمند; Malnutrition; Cancer cachexia; Toxicity; Chemotherapy; Targeted therapy;
Keywords: درمان هدفمند; HNSCC; Cetuximab; Cixutumumab; EGFR; IGF; Targeted therapy;
Keywords: درمان هدفمند; Phase-transformation lipid nanoparticles; Targeted therapy; Ovarian cancer; Paclitaxel; Low-intensity focused ultrasound;
Keywords: درمان هدفمند; Metastatic kidney cancer; mTOR; Next-generation sequencing; Targeted therapy;
Keywords: درمان هدفمند; Cancer of unknown primary (CUP); Targeted therapy; Immune checkpoint inhibitors;
Keywords: درمان هدفمند; Malignant peripheral nerve sheath tumor, MPNST; Neurofibromatosis, neurofibroma, neurofibromin, NF1; RAS signaling; Targeted therapy; Sarcoma; Preclinical studies; Clinical trials;
Keywords: درمان هدفمند; Cancer; Cervix; Endometrium; Gynecologic cancer; Ovary; Pathology; Precision medicine; Targeted therapy; Treatment;
Keywords: درمان هدفمند; Maintenance treatment; CNS lymphoma; Primary CNS lymphoma; Metronomic therapy; Targeted therapy; Immune modulating therapy;
Keywords: درمان هدفمند; Metastatic breast cancer; Targeted therapy; Endocrine therapy; Hormone-receptor positive; Adverse events;
Keywords: درمان هدفمند; Lung cancer; Radiation; Stereotactic radiosurgery; Targeted therapy; Guideline;
Keywords: درمان هدفمند; Targeted therapy; Anti-angiogenic agents; PARP inhibitors; Immunotherapy; Toxicity;
Keywords: درمان هدفمند; Lung cancer; Immunotherapy; Targeted therapy;
Keywords: درمان هدفمند; Chronic liver disease; Angiogenesis; Inhibitors; Targeted therapy;
Keywords: درمان هدفمند; Breast cancer; Targeted therapy; Precision medicine;
Keywords: درمان هدفمند; NSCLC; non-small cell lung cancer; RCTs; randomized controlled trials; OS; overall survival; PFS; progression free survival; ORR; objective response rate; AEs; adverse effects; HR; hazard ratio; RR; relative risk; CI; confidence intervals; FDA; Food and D
Keywords: درمان هدفمند; Breast cancer; Macrophage; Tumor microenvironment; Treatment resistance; Targeted therapy;
Keywords: درمان هدفمند; Chronic lymphocytic leukemia; CLL; Ibrutinib; Idelalisib; Venetoclax; Targeted therapy;
Keywords: درمان هدفمند; AML; acute myeloid leukemia; DFS; disease-free survival; DLBCL; diffuse large B-cell lymphoma; DSPC; 1,2-distearoyl-sn-glycero-3-phosphocholine; DSPE; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine; EPR; enhanced permeation and retention; MB; molecular b
Keywords: درمان هدفمند; Axl inhibitors; Receptor tyrosine kinase; Cancer; Targeted therapy; Small chemicals;
Keywords: درمان هدفمند; Mammalian target of rapamycin; mRCC; Overall survival; Targeted therapy; Vascular endothelial growth factor;
Keywords: درمان هدفمند; Advanced gastric cancer; Peritoneal metastasis; Chemotherapy; Targeted therapy; Regional intraperitoneal chemotherapy; Cytoreductive surgery; HIPEC;
Keywords: درمان هدفمند; Cervix cancer; Neo-adjuvant chemotherapy, adjuvant chemotherapy; Concurrent chemo-radiation; Targeted therapy; Bevacizumab; Immune check point inhibitor;
Keywords: درمان هدفمند; Heart metastasis; Kidney cancer; Left ventricle; Right ventricle; Targeted therapy;
Keywords: درمان هدفمند; Locally advanced NSCLC; Radiochemotherapy; Consolidation therapy; Chemotherapy; Targeted therapy; Immunotherapy;
Keywords: درمان هدفمند; Cancer of unknown primary; Targeted therapy; Monoclonal antibodies; Immune checkpoint inhibitor;
Keywords: درمان هدفمند; AEs; adverse events; EMT/MET; epithelial-mesenchymal transition/mesenchymal-epithelial transition; LPS; liposarcoma; LVEF; left ventricular ejection fraction; STS; soft-tissue sarcomas; Sarcoma; Metastatic disease; Chemotherapy; Epigenetics; Targeted ther
Keywords: درمان هدفمند; Uterine sarcoma; Systemic treatment; Chemotherapy; Hormone therapy; Targeted therapy;
Keywords: درمان هدفمند; Carcinoma; Chemotherapy; Erlotinib; Gefitinib; Targeted therapy;
Keywords: درمان هدفمند; Metastasectomy; Renal cell carcinoma; Metastasis; Targeted therapy; NCDB;
Keywords: درمان هدفمند; ANOVA; analysis of variance; CLSM; confocal laser scanning microscopy; DLS; dynamic light scattering; DMEM-F12; Dulbecco's modified Eagle's medium-F-12; DMSO; dimethyl sulfoxide; EDC; 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; EPR; enhanced perme
Keywords: درمان هدفمند; Renal fibrosis; TGFβ; Pirfenidone; Endothelin-receptor A blockers; Galectin-3; Periostin; DDR1; CB1; miRNA; CKD; Biomarker; Collagen degradation products; Urinary exosomes; Targeted therapy;
Keywords: درمان هدفمند; Antiangiogenic therapy; Metastatic renal-cell carcinoma; mTOR inhibitors; Prognostic factors; Survival; Targeted therapy;
Keywords: درمان هدفمند; BRCA; p53; Predictor; Prognosis; Targeted therapy;
Keywords: درمان هدفمند; Hematological malignancies; Epigenetics; Targeted therapy;
Keywords: درمان هدفمند; Minimal residual disease; Donor lymphocyte infusion; Targeted therapy; Acute leukemia; Myelodysplastic syndrome;
Keywords: درمان هدفمند; Non-small-cell lung cancer; targeted therapy; end-of-life care; aggressive care; hospice;
Keywords: درمان هدفمند; Sarcoma; Gene mutation; P53; RB; PI3K; IDH; Targeted therapy;
Keywords: درمان هدفمند; ACVR1; Activin A receptor type1; ATRX; A-thalassemia/mental retardation syndrome X-linked; BMP; Bone morphogenetic protein; BRAF; v-Raf murine sarcoma viral oncogene homolog B; CNS; Central nervous system; DAXX; Death domain-associated protein; DNMT; DNA
Keywords: درمان هدفمند; ASO; antisense oligonucleotides; BANCR; BRAF-activated non-coding RNA; CCAT1-L; colorectal cancer associated transcript 1-long isoform; cET; constrained EThyl; EMT; epithelial to mesenchymal transition; ERV; endogenous retroviral sequence; FDA; food and d
Keywords: درمان هدفمند; Histone deacetylases; Hepatocellular carcinoma; Targeted therapy;